Log In
Print
BCIQ
Print
Print this Print this
 

Khedezla desvenlafaxine extended-release tablets

  Manage Alerts
Collapse Summary General Information
Company Osmotica Pharmaceutical Corp.
DescriptionExtended-release formulation of a serotonin and norepinephrine reuptake inhibitor
Molecular Target
Mechanism of ActionNorepinephrine reuptake inhibitor; Selective serotonin reuptake inhibitor (SSRI)
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDepression
Indication DetailsTreat major depressive depression (MDD)
Regulatory Designation

Partner

Par Pharmaceutical Cos. Inc.; Pernix Therapeutics Holdings Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today